GATT Technologies

GATT Technologies is a medical device company that has developed a patented synthetic technology aimed at addressing severe and problematic surgical bleeding and organ leakage. The company's hemostatic agents and sealants focus on controlling serious surgical bleeding as well as preventing and treating organ leakage. Currently, the company is working on transferring GATT-Patch (a rapid hemostatic sealing patch for general surgery) to clinical trials in Europe and the United States. Additionally, the company is further developing its other pipeline products, including GATT-Powder (hemostatic agent for laparoscopic use) and GATT-Tape (for intestinal anastomotic leakage), while evaluating other potential applications based on its activated polyoxazoline technology, such as bone regeneration, anti-adhesion, vascular, and ophthalmic uses.